National Health Act 61 of 2003

Related Tags (New Search): Clinical trials,   GCP

Allied Health Professions Act 63 of 1982

Basic Conditions of Employment Act 75 of 1997

CAMs Specified Substances 7.06 v2, Jun 2018

COMPLEMENTARY MEDICINES GUIDANCE ON SPECIFIED SUBSTANCES

Related Tags (New Search): Complementary medicines

AMENDMENT NOTICE Pharmacy Act (53 of 1974) Rules relating to good pharmacy practice BN_84_in_GG_41710_of_15_June_2018

AMENDMENT NOTICE Pharmacy Act (53 of 1974) Rules relating to good pharmacy practice BN_84_in_GG_41710_of_15_June_2018

Hazardous Substances Act 15 of 1973

Mental Health Care Act 17 of 2002

Traditional Health Practitioners Act 22 of 2007

Related Tags (New Search): Complementary medicines

Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act 36 of 1947

9.116_SAHPRA_Update_Civitas_Closure_Oct18_v1

SAHPRA Update Civitas Closure

Interim Adjustment of the Single Exit Price of Medicines and Scheduled Substances (SEPA) for 2016 — GN 893 of 2016

Related Tags (New Search): SEP,   Price adjustments,   Dispensing fees

Degrees, Diplomas and Certificates Obtained Outside the Republic by South African Citizens Which Entitle the Holder to Registration as a Pharmacist — GN R1473 of 1975

Related Tags (New Search): Education,   Qualification

Rules Relating to the Practising of the Para-Veterinary Profession of Veterinary Technologist — GN R1064 of 1991

Minimum Requirements of the Curriculum for a Degree in Pharmacy — GN R1528 of 1994

Related Tags (New Search): Education,   Qualification

Good Pharmacy Practice in South Africa

Related Tags (New Search): GMP,   IVDs

Exemption of Medical Devices and In-Vitro Diagnostics (Ivds) from the Provisions of Sections 18a and 18b of the Act

Rules Relating to the Services for Which a Pharmacist May Levy a Fee and Guidelines for Levying Such a Fee or Fees — GenN 432 of 2017

General Regulations

Related Tags (New Search): Medicines

Transparent Pricing System for Medicines and Scheduled Substances: Information to be Supplied by Pharmacists — GN R584 of 2011

Disposal of Undesirable Medicine — GN R1026 of 2012

Pharmacy Act Overview

Single Exit Price (SEP) for Medicines and Measures to Make Medicines More Affordable

Related Tags (New Search): Dispensing,   Fees,   SEP,   Pharmacoeconomic,   Price adjustments,   Pricing Committee,   Dispensing fees,   Logistics fees

BOOKLET 3: NATIONAL PATIENTS’ RIGHTS CHARTER

The Patient rights charter outlines a patents rights and responsibilities with respect to health care. Please note that this is a third-party website. Juta has no control over the nature, content or availability of third-party websites, and shall not be…

Related Tags (New Search): HPCSA

Dispensing Fees for Authorised Prescribers: GN 1589 in GG 40515

Dispensing Fees for Authorised Prescribers

Related Tags (New Search): Fees

MEDICINES AND RELATED SUBSTANCES AMENDMENT ACT 72 OF 2008, Proc 20 in GG 40869 of 26 May 2017

Amends ss. 1, 15C, 22A, 22C, 22E, 22F, 22H, 28, 29, 30, 31, 34A & 35; repeals ss. 5 to 9 inclusive & 12; inserts s. 24A; and substitutes ss. 2-4, 13-15, 15A,15B, 16-22, 22B, 22D, 23-27, 33A, 36 &…

POSITION STATEMENT: TRANSITIONAL ARRANGEMENTS FOR MEDICAL DEVICES (MCC 9.96, JUN 2017)

Please note that this is a third-party website. Juta has no control over the nature, content or availability of third-party websites, and shall not be liable, in any manner whatsoever, for any damages incurred through the use of third-party websites.

Related Tags (New Search): Licencing,   Medical devices,   IVDs,   Importers,   Wholesaler,   Manufacturers

SAFETY-RELATED PACKAGE INSERT NOTIFICATIONS (SR-PINs) - (MCC: Aug 17)

Safety-related Package Insert Notifications (SR PINS) in South Africa.Circular 2.17.

Related Tags (New Search): Allopathic medicines,   Complementary medicines,   Safety,   Adverse Drug Reaction,   SRPINS,   Adverse Drug Event,   Post-marketing

CLASSIFICATION of MEDICAL DEVICES and IVDs: (MCC: July 17)

Classification of Medical Devices and IVDs

Related Tags (New Search): Medical devices,   IVDs,   Classification

NOTIFICATION STUDIES: PHASE IV (MCC, May 17)

Template for the notification with respect to conducting of phase 4 (post-marketing) studies on medicines in South Africa. Circular 6.24

CLINICAL TRIAL INVESTIGATORS: (MCC, May 17)

Guidelines for clinical trial investigators for clinical research conducted in South Africa. Circular 9.84